CVI Holdings’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

CVI Holdings’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-196,073	Closed	-$2.05M	–	401
2023 Q1	$2.05M	Sell	196,073 -5,242	-3%	-$54.3K	0.77%	44
2022 Q4	$2.07M	Hold	201,315	–	–	0.26%	130
2022 Q3	$2.02M	Hold	201,315	–	–	0.16%	225
2022 Q2	$2M	Hold	201,315	–	–	0.15%	248
2022 Q1	$2M	Buy	201,315 +7,555	+4%	+$75K	0.13%	267
2021 Q4	$1.91M	Buy	+193,760	New	+$1.92M	0.13%	279

CVI Holdings's LVAC Position: Q2 2023 in Review

CVI Holdings sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 196,073 shares — an estimated $2.05M sold.

CVI Holdings first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $2.07M in Q4 2022. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

CVI Holdings reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 196,073 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.05M.
CVI Holdings first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
CVI Holdings's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.07M in Q4 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.